Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Extracellular calcium ion concentration is tightly regulated through the actions of parathyroid hormone (PTH) on kidney and bone. The intact peptide is secreted from the parathyroid glands at a rate that is appropriate to, and dependent upon the prevailing extracellular calcium ion concentration. Hypercalcemic or hypocalcemic disorders can be classified according to whether they arise from an excess or deficiency of PTH, a defect in the receptor for PTH (i.e., the PTH/PTHrP receptor), or insensitivity to PTH caused by defects downstream of the PTH/PTHrP receptor. The PTH gene is located on chromosome 11p15 and consists of three exons, which are separated by two introns. Exon 1 of the PTH gene is 85 bp in length and is untranslated whereas exons 2 and 3 encode the 115 amino acid pre-proPTH peptide.

Original publication

DOI

10.1016/B978-0-12-382040-2.10021-8

Type

Chapter

Book title

Pediatric Bone: Biology and Diseases

Publication Date

28/09/2011

Pages

557 - 588